Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 17, 2017 - Issue 7
Submit an article Journal homepage
416
Views
19
CrossRef citations to date
0
Altmetric
Review

Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review

Mostafa EltobgyFaculty of Medicine, Ain Shams University, Cairo, EgyptView further author information
,
Hani OweiraDepartment of Oncology, Swiss Cancer Institute, Cham, Switzerland;Surgical Center Zurich, Hirslanden Hospital Zurich, Zurich, Switzerland;Department of General, Visceral and Transplant Surgery, University of Heidelberg, Heidelberg, GermanyView further author information
,
Ulf PetrauschOncoCentrum Zurich, Swiss Tumor Immunology Institute (SwissTII), Zurich, SwitzerlandView further author information
,
Daniel HelblingOncoCentrum Zurich, Gastrointestinal Tumor Center Zurich (GITZ), Zurich, SwitzerlandView further author information
,
Jan SchmidtSurgical Center Zurich, Hirslanden Hospital Zurich, Zurich, SwitzerlandView further author information
,
Arianeb MehrabiDepartment of General, Visceral and Transplant Surgery, University of Heidelberg, Heidelberg, GermanyView further author information
,
Othmar SchöbSurgical Center Zurich, Hirslanden Hospital Zurich, Zurich, SwitzerlandView further author information
,
Anwar GiryesDepartment of Oncology, Swiss Cancer Institute, Cham, SwitzerlandView further author information
,
Michael DeckerDepartment of Oncology, Zentrum für Integrative Onkologie, Zurich, SwitzerlandView further author information
&
Omar Abdel-RahmanClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, EgyptCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-5117-2502View further author information
ORCID Icon show all
Pages 725-736 | Received 16 Mar 2017, Accepted 25 May 2017, Published online: 31 May 2017

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Bodil Roth, Danielle Bernadette Schiro & Bodil Ohlsson. (2021) Diseases which cause generalized peripheral neuropathy: a systematic review. Scandinavian Journal of Gastroenterology 56:9, pages 1000-1010.
Read now

Articles from other publishers (18)

Xiangyi Kong, Li Chen, Zhaohui Su, Ryan J. Sullivan, Steven M. Blum, Zhihong Qi, Yulu Liu, Yujia Huo, Yi Fang, Lin Zhang, Jidong Gao & Jing Wang. (2023) Toxicities associated with immune checkpoint inhibitors: a systematic study. International Journal of Surgery 109:6, pages 1753-1768.
Crossref
Rosanna Ruggiero, Nunzia Balzano, Raffaella Di Napoli, Federica Fraenza, Ciro Pentella, Consiglia Riccardi, Maria Donniacuo, Marina Tesorone, Romano Danesi, Marzia Del Re, Francesco Rossi & Annalisa Capuano. (2023) Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years. Frontiers in Immunology 14.
Crossref
Omar Abdel-Rahman. (2021) Association between PD-L1 inhibitor, tumor site and adverse events of potential immune etiology within the US FDA adverse event reporting system. Immunotherapy 13:17, pages 1407-1417.
Crossref
Yu Suzuki, Kenzo Sakurai, Kenji Uchino, Takeo Inoue, Toshiyuki Takahashi, Yasuhiro Hasegawa & Yoshihisa Yamano. (2021) A case of meningoencephalitis that developed during nivolumab use免疫チェックポイント阻害薬の関連が示唆された髄膜脳炎の1例. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 58:4, pages 624-629.
Crossref
Yan Li, Xiuchun Zhang & Chuansheng Zhao. (2021) Guillain-Barré Syndrome-Like Polyneuropathy Associated with Immune Checkpoint Inhibitors: A Systematic Review of 33 Cases. BioMed Research International 2021, pages 1-17.
Crossref
Nagham Al-Zubidi, J. Cody Page, Dan S. Gombos, Akanksha Srivastava, Eric Appelbaum, Paul W. Gidley, Mark S. Chambers & Marc-Elie Nader. 2021. Immunotherapy. Immunotherapy 399 416 .
Mateo Sanchis-Borja, Charles Ricordel, Anne Marie Chiappa, José Hureaux, Luc Odier, Gaelle Jeannin, Renaud Descourt, Radj Gervais, Isabelle Monnet, Jean-Bernard Auliac & Christos Chouaïd. (2020) Encephalitis related to immunotherapy for lung cancer: Analysis of a multicenter cohort. Lung Cancer 143, pages 36-39.
Crossref
Harry J. Han, Yun Rose Li, Mack RoachIIIIII & Rahul Aggarwal. (2020) Dramatic response to combination pembrolizumab and radiation in metastatic castration resistant prostate cancer. Therapeutic Advances in Medical Oncology 12, pages 175883592093608.
Crossref
Akanksha Srivastava, Nagham Al-Zubidi, Eric Appelbaum, Dan S. Gombos, Marc-Elie Nader, Paul W. Gidley & Mark S. Chambers. 2020. Immunotherapy. Immunotherapy 295 307 .
Anna Pavlick & Jeffrey Weber. 2020. Cutaneous Melanoma. Cutaneous Melanoma 1187 1214 .
Peter Chei-way Pan & Aya Haggiagi. (2019) Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibition. Current Oncology Reports 21:12.
Crossref
Omar Abdel-Rahman & Zeinab Elsayed. (2019) Immune checkpoint inhibitors for unresectable hepatocellular carcinoma. Cochrane Database of Systematic Reviews.
Crossref
Omar Abdel-Rahman. (2019) Toxicity patterns associated with chemotherapy/immune checkpoint inhibitor combinations: a meta-analysis. Immunotherapy 11:6, pages 543-554.
Crossref
Omar Abdel-Rahman & Don Morris. (2019) Immune checkpoint inhibitors and non-small-cell lung cancer management: 2018 update. Immunotherapy 11:3, pages 149-153.
Crossref
Anna Pavlick & Jeffrey Weber. 2019. Cutaneous Melanoma. Cutaneous Melanoma 1 28 .
Markus Leitinger, Mihael V. Varosanec, Slaven Pikija, Romana E. Wass, Dave Bandke, Serge Weis, Michael Studnicka, Susanne Grinzinger, Mark R. McCoy, Larissa Hauer & Johann Sellner. (2018) Fatal Necrotizing Encephalopathy after Treatment with Nivolumab for Squamous Non-Small Cell Lung Cancer: Case Report and Review of the Literature. Frontiers in Immunology 9.
Crossref
Omar Abdel-Rahman, Mostafa Eltobgy, Hani Oweira, Anwar Giryes, Aysun Tekbas & Michael Decker. (2017) Immune-related musculoskeletal toxicities among cancer patients treated with immune checkpoint inhibitors: a systematic review. Immunotherapy 9:14, pages 1175-1183.
Crossref
Grenye O'Malley, Hanna J. Lee, Samir Parekh, Matthew D. Galsky, Cardinale B. Smith, Philip Friedlander, Robert T. Yanagisawa & Emily J. Gallagher. (2017) Rapid Evolution of Thyroid Dysfunction in Patients Treated with Nivolumab. Endocrine Practice 23:10, pages 1223-1231.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.